K. Yao

发表

Cellular kinetics of induction by oltipraz and its keto derivative of detoxication enzymes in human colon adenocarcinoma cells.

P. O'dwyer, M. Clayton, T. Halbherr, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Clinical studies of reversal of drug resistance based on glutathione.

P. O'dwyer, K. Yao, T. Hamilton, 1998, Chemico-biological interactions.

Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz.

P. Engstrom, S. Litwin, P. O'dwyer, 1996, The Journal of clinical investigation.

Apoptosis in human adenocarcinoma HT29 cells induced by exposure to hypoxia.

P. O'dwyer, M. Clayton, K. Yao, 1995, Journal of the National Cancer Institute.

Modulation of glutathione and related enzymes in reversal of resistance to anticancer drugs.

R. Ozols, K. Tew, P. O'dwyer, 1995, Hematology/oncology clinics of North America.

Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreas.

P. O'dwyer, K. Yao, J. Stevenson, 1998, European journal of cancer.

Antitumor effect of the angiogenesis inhibitor bevacizumab is dependent on susceptibility of tumors to hypoxia-induced apoptosis.

M. Feldman, P. O'dwyer, K. Yao, 2008, Biochemical pharmacology.

Expression in HT 29 Colon Adenocarcinoma Cells Effects of Hypoxia on Detoxicating Enzyme Activity and Updated

A. Godwin, P. O'dwyer, M. Clayton, 2006 .

Effects of hypoxia on detoxicating enzyme activity and expression in HT29 colon adenocarcinoma cells.

A. Godwin, P. O'dwyer, M. Clayton, 1994, Cancer research.

Involvement of NF-κB in the induction of NAD(P)H: Quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C

P. O'dwyer, K. Yao, 1995 .

Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia.

T. Curran, P. O'dwyer, K. Yao, 1994, Molecular and cellular biology.

The chemopreventive agent oltipraz stimulates repair of damaged DNA.

A. Krueger, P. O'dwyer, K. Yao, 1997, Cancer research.

Role of the AP-1 element and redox factor-1 (Ref-1) in mediating transcriptional induction of DT-diaphorase gene expression by oltipraz: a target for chemoprevention.

P. O'dwyer, K. Yao, 2003, Biochemical pharmacology.

Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia

T. Curran, P. O'dwyer, K. Yao, 1994 .

Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines.

R. Ozols, A. Godwin, P. O'dwyer, 1995, Cancer research.

Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment.

R. Ozols, A. Godwin, P. O'dwyer, 1993, Cancer research.

Interaction of heat and hypoxia in modulating transcription of DT diaphorase in human colon adenocarcinoma cells.

P. O'dwyer, M. Clayton, K. Yao, 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Involvement of NF-kappa B in the induction of NAD(P)H:quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C.

P. O'dwyer, K. Yao, 1995, Biochemical pharmacology.

Increased DT-diaphorase expression and cross-resistance to mitomycin C in a series of cisplatin-resistant human ovarian cancer cell lines.

A. Godwin, R. Perez, P. O'dwyer, 1996, Biochemical pharmacology.

Phase I clinical/pharmacokinetic and pharmacodynamic trial of the c-raf-1 antisense oligonucleotide ISIS 5132 (CGP 69846A).

P. O'dwyer, K. Yao, B. Monia, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

c-raf-1 depletion and tumor responses in patients treated with the c-raf-1 antisense oligodeoxynucleotide ISIS 5132 (CGP 69846A).

P. O'dwyer, K. Yao, B. Monia, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Lactobacillus reuteri 1 Enhances Intestinal Epithelial Barrier Function and Alleviates the Inflammatory Response Induced by Enterotoxigenic Escherichia coli K88 via Suppressing the MLCK Signaling Pathway in IPEC-J2 Cells

Li Wang, K. Yao, Jingchun Gao, 2022, Frontiers in Immunology.

In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo

J. Testa, P. O'dwyer, K. Yao, 2005, British Journal of Cancer.

Macrophage Migration Inhibitory Factor Is a Determinant of Hypoxia-Induced Apoptosis in Colon Cancer Cell Lines

Steven W. Johnson, P. O'dwyer, K. Yao, 2005, Clinical Cancer Research.

Clinical, pharmacokinetic and biological studies of topotecan

P. O'dwyer, T. Halbherr, K. Yao, 2004, Cancer Chemotherapy and Pharmacology.

Reversal of cisplatin resistance in human ovarian cancer cell lines by a c-jun antisense oligodeoxynucleotide (ISIS 10582): evidence for the role of transcription factor overexpression in determining resistant phenotype.

P. O'dwyer, K. Yao, B. Monia, 2002, Biochemical pharmacology.

Chronic dosing of oltipraz in people at increased risk for colorectal cancer.

P. Engstrom, S. Litwin, P. O'dwyer, 2001, Cancer detection and prevention.